These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1311 related articles for article (PubMed ID: 22992668)

  • 1. Pharmacogenomics knowledge for personalized medicine.
    Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
    Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGxMine: Text mining for curation of PharmGKB.
    Lever J; Barbarino JM; Gong L; Huddart R; Sangkuhl K; Whaley R; Whirl-Carrillo M; Woon M; Klein TE; Altman RB
    Pac Symp Biocomput; 2020; 25():611-622. PubMed ID: 31797632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semantically enabling pharmacogenomic data for the realization of personalized medicine.
    Samwald M; Coulet A; Huerga I; Powers RL; Luciano JS; Freimuth RR; Whipple F; Pichler E; Prud'hommeaux E; Dumontier M; Marshall MS
    Pharmacogenomics; 2012 Jan; 13(2):201-12. PubMed ID: 22256869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PharmGKB, an Integrated Resource of Pharmacogenomic Knowledge.
    Gong L; Whirl-Carrillo M; Klein TE
    Curr Protoc; 2021 Aug; 1(8):e226. PubMed ID: 34387941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PharmGKB Tutorial for Pharmacogenomics of Drugs Potentially Used in the Context of COVID-19.
    Huddart R; Whirl-Carrillo M; Altman RB; Klein TE
    Clin Pharmacol Ther; 2021 Jan; 109(1):116-122. PubMed ID: 32978778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PharmGKB: the Pharmacogenomics Knowledge Base.
    Thorn CF; Klein TE; Altman RB
    Methods Mol Biol; 2013; 1015():311-20. PubMed ID: 23824865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
    Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
    Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNP web resources and their potential applications in personalized medicine.
    Wang J; Pang GS; Chong SS; Lee CG
    Curr Drug Metab; 2012 Sep; 13(7):978-90. PubMed ID: 22591348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and bioinformatics: PharmGKB.
    Thorn CF; Klein TE; Altman RB
    Pharmacogenomics; 2010 Apr; 11(4):501-5. PubMed ID: 20350130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
    Whirl-Carrillo M; Huddart R; Gong L; Sangkuhl K; Thorn CF; Whaley R; Klein TE
    Clin Pharmacol Ther; 2021 Sep; 110(3):563-572. PubMed ID: 34216021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and individualized medicine: translating science into practice.
    Crews KR; Hicks JK; Pui CH; Relling MV; Evans WE
    Clin Pharmacol Ther; 2012 Oct; 92(4):467-75. PubMed ID: 22948889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge.
    Hodge AE; Altman RB; Klein TE
    Clin Pharmacol Ther; 2007 Jan; 81(1):21-4. PubMed ID: 17185992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base.
    Klein TE; Chang JT; Cho MK; Easton KL; Fergerson R; Hewett M; Lin Z; Liu Y; Liu S; Oliver DE; Rubin DL; Shafa F; Stuart JM; Altman RB
    Pharmacogenomics J; 2001; 1(3):167-70. PubMed ID: 11908751
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery.
    Radhakrishnan A; Kuppusamy G; Ponnusankar S; Shanmukhan NK
    Pharmacogenomics J; 2020 Feb; 20(1):1-18. PubMed ID: 31819163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics in the clinic.
    Relling MV; Evans WE
    Nature; 2015 Oct; 526(7573):343-50. PubMed ID: 26469045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conference scene: pediatric pharmacogenomics and personalized medicine.
    Leeder JS; Lantos J; Spielberg SP
    Pharmacogenomics; 2010 Dec; 11(12):1691-702. PubMed ID: 21142913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future prospects for pharmacogenetics in the quest for personalized medicine.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2012 Dec; 50(12):13-6. PubMed ID: 23457712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB).
    Owen RP; Klein TE; Altman RB
    Clin Pharmacol Ther; 2007 Oct; 82(4):472-5. PubMed ID: 17713470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PharmGKB and the International Warfarin Pharmacogenetics Consortium: the changing role for pharmacogenomic databases and single-drug pharmacogenetics.
    Owen RP; Altman RB; Klein TE
    Hum Mutat; 2008 Apr; 29(4):456-60. PubMed ID: 18330919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.